血管重塑:肺高血压的多细胞机制
Jinjin Dai1,2,3, Hongyang Chen1,2,3, Jindong Fang1,2,3
1School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming 650500, China.
International journal of molecular sciences
|May 14, 2025
概括
肺高血压 (PH) 涉及复杂的细胞变化和血管重塑. 了解这些机制和细胞交叉通话为PH治疗提供了新的治疗点.
科学领域:
- 心血管研究研究心血管研究
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
背景情况:
- 肺高血压 (PH) 是一种严重的心血管疾病,其特征是肺血管阻力升高和肺动脉平均压力.
- 它导致右心室缩,心力衰竭和死亡率.
- 血管改造,包括血管收缩,增殖,炎症和亡抵抗,是PH进展的核心.
研究的目的:
- 审查PH中的肺血管重塑中的细胞机制和细胞间交叉声.
- 突出最近在理解信号通路,炎症,亡和PH中的扩散方面取得的进展.
- 确定潜在的治疗策略,针对这些生物功能进行PH治疗.
主要方法:
- 在PubMed,Embase,Web of Science和谷歌学者的系统文献搜索.
- 专注于人类和动物PH的研究,强调血管改造.
- 在PH中合成关于细胞变化和细胞间通信的信息.
主要成果:
- 在PH中血管重塑涉及肺动脉内皮细胞功能障碍,光滑肌肉细胞增殖,纤维细胞分化,免疫细胞炎症和细胞细胞增殖.
- 这些细胞之间的细胞间交叉是PH病原发生的关键.
- 涉及各种细胞信号通路,炎症反应,亡和增殖过程.
结论:
- 了解PH中血管重塑的复杂细胞和分子机制至关重要.
- 针对特定的细胞功能及其交叉通话,为PH提供了有前途的治疗途径.
- 本综述为开发肺高血压新型治疗方法提供了洞察力.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
126
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
126
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
334
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
334
Vascular Resistance
3.1K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
3.1K


